Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.21 - $5.63 $5,250 - $140,750
25,000 Added 7.1%
376,873 $97,000
Q3 2022

Nov 14, 2022

SELL
$0.46 - $6.75 $16,611 - $243,749
-36,111 Reduced 9.31%
351,873 $143,000
Q2 2022

Aug 15, 2022

BUY
$0.27 - $0.61 $21,600 - $48,800
80,000 Added 25.98%
387,984 $198,000
Q1 2022

May 13, 2022

BUY
$0.5 - $0.88 $37,000 - $65,120
74,000 Added 31.63%
307,984 $82,000
Q4 2021

Feb 17, 2022

BUY
$0.58 - $1.09 $2,891 - $5,433
4,985 Added 2.18%
233,984 $136,000
Q3 2021

Oct 25, 2021

BUY
$0.93 - $1.18 $74,530 - $94,565
80,140 Added 53.84%
228,999 $259,000
Q2 2021

Aug 09, 2021

BUY
$1.19 - $2.06 $24,186 - $41,869
20,325 Added 15.81%
148,859 $177,000
Q1 2021

May 10, 2021

BUY
$1.62 - $3.05 $136,118 - $256,273
84,024 Added 188.78%
128,534 $265,000
Q4 2020

Feb 12, 2021

SELL
$1.44 - $1.98 $28,494 - $39,180
-19,788 Reduced 30.78%
44,510 $69,000
Q3 2020

Nov 09, 2020

BUY
$0.8 - $2.33 $32,958 - $95,991
41,198 Added 178.35%
64,298 $111,000
Q2 2020

Aug 03, 2020

BUY
$0.75 - $1.29 $17,325 - $29,799
23,100 New
23,100 $19,000
Q2 2020

Jul 31, 2020

SELL
$0.75 - $1.29 $17,925 - $30,832
-23,901 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$0.33 - $1.62 $1,188 - $5,833
3,601 Added 17.74%
23,901 $23,000
Q4 2019

Jan 28, 2020

BUY
$1.23 - $2.67 $9,594 - $20,826
7,800 Added 62.4%
20,300 $32,000
Q3 2019

Oct 15, 2019

SELL
$1.25 - $5.0 $4,032 - $16,130
-3,226 Reduced 20.51%
12,500 $27,000
Q2 2019

Aug 13, 2019

BUY
$1.65 - $6.72 $25,947 - $105,678
15,726 New
15,726 $31,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $1.09B
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Jaffetilchin Investment Partners, LLC Portfolio

Follow Jaffetilchin Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.